Agilent Technologies A Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Agilent CrossLab | $759M+6.5% | $758M+8.9% | $755M+6.9% | $744M+7.7% | $713M+7.4% | |
| Applied Markets | $344M+14.3% | $361M+6.8% | $351M+3.8% | $324M+7.3% | $301M-1.3% | |
| Life Sciences and Diagnostics Markets | $732M+11.9% | $679M+4.9% | $755M+14.9% | $670M+14.5% | $654M+8.3% | |
| Net revenue by Product | ||||||
| Instrumentation | $618M+12.4% | $658M+5.3% | $653M+5.3% | $599M+7.7% | $550M+0.4% | |
| Non-Instrumentation and Other | $1.22B+8.9% | $1.14B+8.0% | $1.21B+11.7% | $1.14B+11.4% | $1.12B+9.1% | |
| Services and Other | $530M+10.0% | $525M+9.1% | $533M+10.1% | $508M+11.2% | $482M+7.6% | |
| Net revenue by Geography | ||||||
| Americas | $764M+12.7% | $678M+1.3% | $776M+14.1% | $683M+9.1% | $678M+6.4% | |
| Asia Pacific | $553M+0.9% | $602M+9.7% | $559M-1.4% | $563M+8.3% | $548M+7.5% | |
| Europe | $518M+17.2% | $518M+11.9% | $526M+15.9% | $492M+13.9% | $442M+3.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Agilent Technologies break its business down?
- Agilent Technologies (A) reports net revenue by business across 3 parts — Agilent CrossLab, Applied Markets and Life Sciences and Diagnostics Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Agilent Technologies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Agilent Technologies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
